TNFRSF11A and atherosclerosis: One study suggested that bisphosphonates may inhibit the differentiation of vascular smooth muscle cells into osteoblast-like cells and regulate the OPG–RANK–RANKL pathway, potentially suppressing atherosclerosis and reducing the risk of cardiovascular disease [34].